Influenza Virus Vaccine and Egg Allergy [Abridged]
Many vaccines, including influenza vaccine, are prepared from viruses grown in the allantoic cavity of chicken egg. Ratner & Untracht (1946) pointed out that serious reactions, including fatalities, had occurred in egg allergic patients given these vaccines. In their investigation all patients with positive skin tests to egg white protein gave positive skin reactions on intradermal testing to influenza A and B vaccine, and they suggested a preliminary intradermal test with 0.02 ml of the undiluted vaccine in patients thought to be allergic to egg. Unfortunately this intradermal test dose was sufficient to cause urticaria and asthma in some hypersensitive patients. Recently, the separation of influenza virus by zonal centrifugation has improved the purity of the vaccine to the extent where only 10% of the polypeptide present are thought to be of egg rather than viral origin (Duphar Laboratories Ltd 1974, personal communication).
An investigation was carried out to examine he relationship between a clinical history of Ilergy to egg and the results of skin testing with gg extracts, the presence or absence of precipitating antibody in the serum and the levels of specific IgE antibody against egg white, egg yolk and allantoic fluid. Allergic reactions to the newer, more highly purified influenza vaccines were looked for and safe methods sought for detection of this hypersensitivity in egg allergic patients who might otherwise benefit from the administration of the vaccine.
Seventy patients with asthma were studied, selected so that half gave a possible or definite history of allergy to egg. The patients giving a definite history of reactions such as urticaria, asthma or vomiting, occurring after ingestion or contact with egg or egg-containing materials, more frequently showed positive skin prick tests to egg extracts than patients with only a possible or no such history (P=<0.003). Further, the
